| 1 |
Marcellin P, Kutala BK. Liver diseases: a major, neglected global public health problem requiring urgent actions and large-scale screening[J]. Liver Int, 2018, 38 (Suppl 1): 2-6.
|
| 2 |
万鹏夏，沈鸣雁，李长玲，等.肝移植患者围术期分阶段血液净化治疗的护理[J/CD].中华危重症医学杂志（电子版），2022，15（5）：438-440.
|
| 3 |
Mendizabal M, Silva MO. Liver transplantation in acute liver failure: a challenging scenario[J]. World J Gastroenterol, 2016, 22 (4): 1523-1531.
|
| 4 |
Pan XP, Li LJ. Advances in cell sources of hepatocytes for bioartificial liver[J]. Hepatobiliary Pancreat Dis Int, 2012, 11 (6): 594-605.
|
| 5 |
Hu C, Zhao L, Zhang L, et al. Mesenchymal stem cell-based cell-free strategies: safe and effective treatments for liver injury[J]. Stem Cell Res Ther, 2020, 11 (1): 377.
|
| 6 |
Qu Y, Zhang Q, Cai X, et al. Exosomes derived from miR-181-5p-modified adipose-derived mesenchymal stem cells prevent liver fibrosis via autophagy activation[J]. J Cell Mol Med, 2017, 21 (10): 2491-2502.
|
| 7 |
Ko SF, Yip HK, Zhen YY, et al. Adipose-derived mesenchymal stem cell exosomes suppress hepatocellular carcinoma growth in a rat model: apparent diffusion coefficient, natural killer T-cell responses, and histopathological features[J]. Stem Cells Int, 2015 (2015): 853506.
|
| 8 |
Pilkington AC, Paz HA, Wankhade UD. Beige adipose tissue identification and marker specificity—overview[J]. Front Endocrinol (Lausanne), 2021 (12): 599134.
|
| 9 |
Cui J, Shen W, Zhao H. New insights into extracellular vesicles between adipocytes and breast cancer orchestrating tumor progression[J]. Front Biosci (Landmark Ed), 2023, 28 (6): 129.
|
| 10 |
Ong WK, Chakraborty S, Sugii S. Adipose tissue: understanding the heterogeneity of stem cells for regenerative medicine[J]. Biomolecules, 2021, 11 (7): 918.
|
| 11 |
Hyenne V, Apaydin A, Rodriguez D, et al. RAL-1 controls multivesicular body biogenesis and exosome secretion[J]. J Cell Biol, 2015, 211 (1): 27-37.
|
| 12 |
T Ramos R, Sánchez-Abarca LI, Muntión S, et al. MSC surface markers (CD44, CD73, and CD90) can identify human MSC-derived extracellular vesicles by conventional flow cytometry[J]. Cell Commun Signal, 2016 (14): 2.
|
| 13 |
Kim HS, Choi DY, Yun SJ, et al. Proteomic analysis of microvesicles derived from human mesenchymal stem cells[J]. J Proteome Res, 2012, 11 (2): 839-849.
|
| 14 |
Kou M, Huang L, Yang J, et al. Mesenchymal stem cell-derived extracellular vesicles for immunomodulation and regeneration: a next generation therapeutic tool?[J]. Cell Death Dis, 2022, 13 (7): 580.
|
| 15 |
Wu R, Fan X, Wang Y, et al. Mesenchymal stem cell-derived extracellular vesicles in liver immunity and therapy[J]. Front Immunol, 2022 (13): 833878.
|
| 16 |
Dewidar B, Meyer C, Dooley S, et al. TGF-β in hepatic stellate cell activation and liver fibrogenesis—updated 2019[J]. Cells, 2019, 8 (11): 1419.
|
| 17 |
Du Z, Wu T, Liu L, et al. Extracellular vesicles-derived miR-150-5p secreted by adipose-derived mesenchymal stem cells inhibits CXCL1 expression to attenuate hepatic fibrosis[J]. J Cell Mol Med, 2021, 25 (2): 701-715.
|
| 18 |
Zhang Z, Shang J, Yang Q, et al. Exosomes derived from human adipose mesenchymal stem cells ameliorate hepatic fibrosis by inhibiting PI3K/Akt/mTOR pathway and remodeling choline metabolism[J]. J Nanobiotechnology, 2023, 21 (1): 29.
|
| 19 |
Zhu M, Liu X, Li W, et al. Exosomes derived from mmu_circ_0000623-modified ADSCs prevent liver fibrosis via activating autophagy[J]. Hum Exp Toxicol, 2020, 39 (12): 1619-1627.
|
| 20 |
Lou G, Yang Y, Liu F, et al. MiR-122 modification enhances the therapeutic efficacy of adipose tissue-derived mesenchymal stem cells against liver fibrosis[J]. J Cell Mol Med, 2017, 21 (11): 2963-2973.
|
| 21 |
Yang C, Luo L, Bai X, et al. Highly-expressed micoRNA-21 in adipose derived stem cell exosomes can enhance the migration and proliferation of the HaCaT cells by increasing the MMP-9 expression through the PI3K/AKT pathway[J]. Arch Biochem Biophys, 2020 (681): 108259.
|
| 22 |
Motawi TM, Atta HM, Sadik NA, et al. The therapeutic effects of bone marrow-derived mesenchymal stem cells and simvastatin in a rat model of liver fibrosis[J]. Cell Biochem Biophys, 2014, 68 (1): 111-125.
|
| 23 |
Baldari S, Di Rocco G, Magenta A, et al. Extracellular vesicles-encapsulated microrna-125b produced in genetically modified mesenchymal stromal cells inhibits hepatocellular carcinoma cell proliferation[J]. Cells, 2019, 8 (12): 1560.
|
| 24 |
Lou G, Song X, Yang F, et al. Exosomes derived from miR-122-modified adipose tissue-derived MSCs increase chemosensitivity of hepatocellular carcinoma[J]. J Hematol Oncol, 2015 (8): 122.
|
| 25 |
Lou G, Chen L, Xia C, et al. MiR-199a-modified exosomes from adipose tissue-derived mesenchymal stem cells improve hepatocellular carcinoma chemosensitivity through mTOR pathway[J]. J Exp Clin Cancer Res, 2020, 39 (1): 4.
|
| 26 |
Huang Y, Yang L. Mesenchymal stem cell-derived extracellular vesicles in therapy against fibrotic diseases[J]. Stem Cell Res Ther, 2021 (12): 435.
|
| 27 |
Han HS, Lee H, You D, et al. Human adipose stem cell-derived extracellular nanovesicles for treatment of chronic liver fibrosis[J]. J Control Release, 2020 (320): 328-336.
|
| 28 |
Gupta S, Pinky, Vishal, et al. Comparative evaluation of anti-fibrotic effect of tissue specific mesenchymal stem cells derived extracellular vesicles for the amelioration of CCl4 induced chronic liver injury[J]. Stem Cell Rev Rep, 2022, 18 (3): 1097-1112.
|
| 29 |
Wu B, Feng J, Guo J, et al. ADSCs-derived exosomes ameliorate hepatic fibrosis by suppressing stellate cell activation and remodeling hepatocellular glutamine synthetase-mediated glutamine and ammonia homeostasis[J]. Stem Cell Res Ther, 2022, 13 (1): 494.
|
| 30 |
Domínguez LM, Bueloni B, Cantero MJ, et al. Chromatographic scalable method to isolate engineered extracellular vesicles derived from mesenchymal stem cells for the treatment of liver fibrosis in mice[J]. Int J Mol Sci, 2023, 24 (11): 9586.
|
| 31 |
Yao L, Hu X, Dai K, et al. Mesenchymal stromal cells: promising treatment for liver cirrhosis[J]. Stem Cell Res Ther, 2022, 13 (1): 308.
|
| 32 |
Wang J, Ye W, Jiang M, et al. Therapeutic potential of exosome derived from hepatocyte growth factor-overexpressing adipose mesenchymal stem cells in TGFβ1-stimulated hepatic stellate cells[J]. Cytotechnology, 2024, 76 (2): 217-229.
|
| 33 |
Moris D, Beal EW, Chakedis J, et al. Role of exosomes in treatment of hepatocellular carcinoma[J]. Surg Oncol, 2017, 26 (3): 219-228.
|